Global Anti-Streptolysin Reagents Market By Analysis (Qualitative, Semi-Quantitative, Quantitative), By End-User (Hospitals, Research Laboratories, Diagnostic Laboratories, Academic & Research Institutes), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031
- account_circleAbout Me
- 74551
-
US $6,000US $3,999
-
US $8,000US $5,999
-
US $10,000US $6,999
Streptolysin is a hemolytic exotoxin generated by Streptococcaceae bacteria. Streptolysin O (SLO) and Streptolysin S (SLS) are two forms of streptomycin, with SLO being more hemolytically active than SLS due to its larger size.
To measure the quantities of antibodies generated against SLO, anti-streptolysin reagents, kits, assays, and titers are used. Anti-streptolysin reagents are used to titrate anti-streptolysin reagents with a patient's serum sample to assess the toxicity and levels of SLO.
Acute rheumatic fever or acute post-streptococcal glomerulonephritis can be caused by infections, which can be diagnosed using anti-streptolysin reagents. To check for toxins, anti-streptolysin reagents, as well as appropriate calibrators and controls are commonly available in kits from various vendors.
Anti-streptolysin reagents provide valuable information for infection diagnosis and monitoring. Scarlet fever, tonsillitis, otitis, and erysipelas are among the illnesses that can be detected. The market for anti-streptolysin reagents is expected to increase as people become more aware of the signs and symptoms caused by antibodies produced.
Detailed Segmentation –
Analysis Type:
- Qualitative
- Semi-Quantitative
- Quantitative
End-User:
- Hospitals
- Research Laboratories
- Diagnostic Laboratories
- Academic & Research Institutes
Based on Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Market Dynamics –
Driver for the Global Anti-Streptolysin Reagents Market:
The increasing availability of anti-streptolysin reagent kits over-the-counter is expected to lead to greater revenues, thereby boosting the anti-streptolysin reagents market in the process. Owing to the surging frequency of otitis and tonsillitis among youngsters, the anti-streptolysin reagents market is expected to augment gradually in years to come.
Restraints Global Anti-Streptolysin Reagents Market:
Opportunities for the Global Anti-Streptolysin Reagents Market:
Anti-streptolysin reagents are expected to be in high demand from research and academic institutes for educational purposes, creating a stable demand for anti-streptolysin reagents. Hemolysis caused by infections in post-surgical operations is also expected to lead to further expansion potential for the anti-streptolysin reagents market.
Trends for the Global Anti-Streptolysin Reagents Market:
Acute pharyngitis, one of the most prevalent infections of the throat, and its increasing prevalence across the globe is expected to aid in boosting the revenue growth trajectory of the anti-streptolysin reagents market. As more contract research & development organizations focus on understanding the efficacy and cytotoxicity of reactions, the potential for the anti-streptolysin reagents market to subsequently grow is increase.
Competitive Landscape –
- Biosystems S.A.
- Randox Laboratories Ltd.
- Kamiya Biomedical Company
- ELITechGroup
- Erba Lachema S.R.O.
- Lab Care Diagnostics (India) Pvt. Ltd.
- Adaltis S.r.l.
- Lorne Laboratories Limited
- DiaSys Diagnostic Systems GmbH
- Diagnostic Automation/Cortez Diagnostics Inc.
For the Anti-Streptolysin Reagents Market research study, the following years have been considered to estimate the market size:
Particular Scope Region - North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Historic Year 2016 to 2020 Base Year 2021 Estimated Year 2022 Forecast Year 2023 to 2032 - account_circleAbout Me
- 74551
-
US $6,000US $3,999
-
US $8,000US $5,999
-
US $10,000US $6,999
- 1.Anti-Streptolysin Reagents Market Introduction
- 1.1.Definition
- 1.2.Taxonomy
- 1.3.Research Scope
- 2.Executive Summary
- 2.1.Key Findings by Major Segments
- 2.2.Top strategies by Major Players
- 3.Global Anti-Streptolysin Reagents Market Overview
- 3.1.Anti-Streptolysin Reagents Market Dynamics
- 3.1.1.Drivers
- 3.1.2.Opportunities
- 3.1.3.Restraints
- 3.1.4.Challenges
- 3.2.COVID-19 Impact Analysis
- 3.3.COVID-19 Impact Analysis in Global Anti-Streptolysin Reagents Market
- 3.4.PESTLE Analysis
- 3.5.Opportunity Map Analysis
- 3.6.PORTER'S Five Forces Analysis
- 3.7.Market Competition Scenario Analysis
- 3.8.Product Life Cycle Analysis
- 3.9.Opportunity Orbits
- 3.10.Manufacturer Intensity Map
- 3.11.Major Companies sales by Value & Volume
- 3.1.Anti-Streptolysin Reagents Market Dynamics
- 4.Global Anti-Streptolysin Reagents Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Analysis Type, 2016-2032
- 4.1.Global Anti-Streptolysin Reagents Market Analysis by Analysis Type: Introduction
- 4.2.Market Size and Forecast by Region
- 4.3.Qualitative
- 4.4.Semi-Quantitative
- 4.5.Quantitative
- 5.Global Anti-Streptolysin Reagents Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by End-User, 2016-2032
- 5.1.Global Anti-Streptolysin Reagents Market Analysis by End-User: Introduction
- 5.2.Market Size and Forecast by Region
- 5.3.Hospitals
- 5.4.Research Laboratories
- 5.5.Diagnostic Laboratories
- 5.6.Academic & Research Institutes
- 6.Global Anti-Streptolysin Reagents Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2016-2032
- 6.1.North America
- 6.1.1.North America Anti-Streptolysin Reagents Market: Regional Trend Analysis
- 6.1.1.1.U.S.
- 6.1.1.2.Canada
- 6.1.1.3.Mexico
- 6.1.1.North America Anti-Streptolysin Reagents Market: Regional Trend Analysis
- 6.2.1.Europe
- 6.2.1.Europe Anti-Streptolysin Reagents Market: Regional Trend Analysis
- 6.2.1.1.U.K.
- 6.2.1.2.Germany
- 6.2.1.3.France
- 6.2.1.4.Spain
- 6.2.1.5.Italy
- 6.2.1.6.Russia
- 6.2.1.7.Rest of Europe
- 6.2.1.Europe Anti-Streptolysin Reagents Market: Regional Trend Analysis
- 6.3.Asia-Pacific
- 6.3.1.Asia-Pacific Anti-Streptolysin Reagents Market: Regional Trend Analysis
- 6.3.1.1.China
- 6.3.1.2.Japan
- 6.3.1.3.South Korea
- 6.3.1.4.India
- 6.3.1.5.ASEAN
- 6.3.1.6.Rest of Asia-Pacific
- 6.3.1.Asia-Pacific Anti-Streptolysin Reagents Market: Regional Trend Analysis
- 6.4.Latin America
- 6.4.1.Latin America Anti-Streptolysin Reagents Market: Regional Trend Analysis
- 6.4.1.1.Brazil
- 6.4.1.2.Argentina
- 6.4.1.3.Rest of Latin America
- 6.4.1.Latin America Anti-Streptolysin Reagents Market: Regional Trend Analysis
- 6.5.Middle East and Africa
- 6.5.1.Middle East and Africa Anti-Streptolysin Reagents Market: Regional Trend Analysis
- 6.5.1.1.GCC
- 6.5.1.2.Israel
- 6.5.1.3.South Africa
- 6.5.1.4.Rest of MEA
- 6.5.1.Middle East and Africa Anti-Streptolysin Reagents Market: Regional Trend Analysis
- 6.1.North America
- 7.Global Anti-Streptolysin Reagents Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 7.1.Market Share Analysis
- 7.2.Company Profiles
- 7.3.Biosystems S.A.
- 7.3.1.Company Overview
- 7.3.2.Financial Highlights
- 7.3.3.Product Portfolio
- 7.3.4.SWOT Analysis
- 7.3.5.Key Strategies and Developments
- 7.4.Randox Laboratories Ltd.
- 7.4.1.Company Overview
- 7.4.2.Financial Highlights
- 7.4.3.Product Portfolio
- 7.4.4.SWOT Analysis
- 7.4.5.Key Strategies and Developments
- 7.5.Kamiya Biomedical Company
- 7.5.1.Company Overview
- 7.5.2.Financial Highlights
- 7.5.3.Product Portfolio
- 7.5.4.SWOT Analysis
- 7.5.5.Key Strategies and Developments
- 7.6.ELITechGroup
- 7.6.1.Company Overview
- 7.6.2.Financial Highlights
- 7.6.3.Product Portfolio
- 7.6.4.SWOT Analysis
- 7.6.5.Key Strategies and Developments
- 7.7.Erba Lachema S.R.O.
- 7.7.1.Company Overview
- 7.7.2.Financial Highlights
- 7.7.3.Product Portfolio
- 7.7.4.SWOT Analysis
- 7.7.5.Key Strategies and Developments
- 7.8.Lab Care Diagnostics (India) Pvt. Ltd.
- 7.8.1.Company Overview
- 7.8.2.Financial Highlights
- 7.8.3.Product Portfolio
- 7.8.4.SWOT Analysis
- 7.8.5.Key Strategies and Developments
- 7.9.Adaltis S.r.l.
- 7.9.1.Company Overview
- 7.9.2.Financial Highlights
- 7.9.3.Product Portfolio
- 7.9.4.SWOT Analysis
- 7.9.5.Key Strategies and Developments
- 7.10.Lorne Laboratories Limited
- 7.10.1.Company Overview
- 7.10.2.Financial Highlights
- 7.10.3.Product Portfolio
- 7.10.4.SWOT Analysis
- 7.10.5.Key Strategies and Developments
- 7.11.DiaSys Diagnostic Systems GmbH
- 7.11.1.Company Overview
- 7.11.2.Financial Highlights
- 7.11.3.Product Portfolio
- 7.11.4.SWOT Analysis
- 7.11.5.Key Strategies and Developments
- 7.12.Diagnostic Automation/Cortez Diagnostics Inc.
- 7.12.1.Company Overview
- 7.12.2.Financial Highlights
- 7.12.3.Product Portfolio
- 7.12.4.SWOT Analysis
- 7.12.5.Key Strategies and Developments
- 8.Assumptions and Acronyms
- 9.Research Methodology
- 10.Contact
- ondemand_videoVideos
- 74551
-
US $6,000US $3,999
-
US $8,000US $5,999
-
US $10,000US $6,999
- Biosystems S.A.
- Randox Laboratories Ltd.
- Kamiya Biomedical Company
- ELITechGroup
- Erba Lachema S.R.O.
- Lab Care Diagnostics (India) Pvt. Ltd.
- Adaltis S.r.l.
- Lorne Laboratories Limited
- DiaSys Diagnostic Systems GmbH
- Diagnostic Automation/Cortez Diagnostics Inc.
- settingsSettings